相关实验视频

Updated: May 6, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

MYD88^L256P突变的发生频率和相关性慢性炎症性去乙烯化多基原蛋白神经病变和多焦点运动神经病变中的突变

Alexandre Guérémy¹, John Boudjarane², Emilie Alazard²

¹Referral Center for Neuromuscular Diseases and ALS, La Timone Hospital, Marseille, France.

European journal of neurology

|July 28, 2025

概括

获得的MYD88^L256P突变在慢性炎症性脱髓化多基原蛋白神经病变 (CIDP) 和多焦点运动神经病变 (MMN) 中很常见. 这一发现表明了对这些疾病的原因和治疗方法的新研究.

科学领域:

免疫学免疫学免疫学
神经学神经学
遗传学是一个遗传学.

背景情况:

骨髓分化主响应88 (MYD88) 蛋白通过托尔类和互白素-1受体调节免疫反应.
获得的MYD88^L256P突变增强了蛋白质活性,可能导致炎症和自身免疫性疾病.

研究的目的:

调查MYD88^L256P突变在CIDP和MMN中的频率.
评估突变对这些神经病变的临床表现的影响.

主要方法:

MYD88^L256P突变分析来自79名CIDP患者,35名MMN患者和57名对照患者的外周血液单核细胞.
使用残疾分数,神经纤维光链水平,运动单元计数和电诊断测试来评估疾病严重程度.

主要成果:

与对照组 (2%) 相比,MYD88^L256P突变在MMN (34%) 和CIDP (19%) 患者中明显更为普遍.
患有这种突变的患者患有IgM单克隆性胃病变的可能性更高,尽管即使排除了这种突变,这种突变仍然很常见.
疾病严重程度和对静脉注射免疫球蛋白的治疗反应在突变和非突变患者之间是相似的.

结论:

MYD88^L256P突变是CIDP和MMN中经常发现的.
这表明了这些神经病变的新型病理生理机制和潜在的治疗点.

关键词:

在CIDP中,我们可以看到.在MYD8888上,你会看到MYD8888的情况.多焦点运动神经病变.

更多相关视频

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

Published on: November 27, 2014

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...